Stay updated on Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new site in Ciudad de Buenos Aires, Argentina (C1120AAT) was added on 2026-02-27, and the Buenos Aires, Argentina site was removed on 2025-10-28.
    Difference
    0.3%
    Check dated 2026-03-04T23:47:48.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; the page removed the funding-lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:21:39.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Notice added about potential delays due to a lapse in government funding and the NIH Clinical Center's operating status. Website revision updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:54:13.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Show glossary option added; several metadata labels updated or added (Last Update Submitted that Met QC Criteria, Last Update Posted, Revision: v3.4.0) while corresponding older labels and No FEAR Act data references (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4) were removed or changed. These changes are limited to UI/metadata and do not affect core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:00:53.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The revision header now shows v3.3.4 instead of v3.3.3, a minor versioning update with no impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:54:12.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Locations now include California; references to California Locations and Revision: v3.3.2 were removed, with the page upgraded to Revision v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:06:33.000Z thumbnail image

Stay in the know with updates to Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.